Quinine Lawsuit - Quinine Side Effects - Quinine Dangers
Posted: Thursday, March 29, 2007
by T Going
On December 13, 2006 the Food and Drug Administration stepped up its role in protecting the public health by cracking down on off-label uses of potentially dangerous drugs to treat relatively less serious conditions. There are a number of companies that market the drug quinine as an effective treatment for a leg cramps and other assorted conditions, but there is only one FDA-approved quinine product and it is intended to treat the tropical disease malaria.
Quinine can cause a number of extremely serious side effects including:
• Birth Defects such as deafness
• Miscarriage
• Hemolytic anemia in some people
• Cinchonism
• Pulmonary Edema
• Immune Thrombocytopenic Purpura
In addition, quinine can aggravate these conditions and should not be used in people with:
• Haemoglobinuria: high content of hemoglobin in urine
• Myasthenia gravis: a neuromuscular disease that causes muscle weakness and fatigue
• Optic Neuritis: inflammation of the optic nerve that can result in partial or total loss of vision
• Atrial fibrillation
• Heart blocks
• Conduction defects
The consequences of off-label quinine use are tragic and heartbreaking. The FDA has received reports of 665 adverse reactions to quinine since 1969, and there have also sadly been 93 deaths due to unsupervised use of the drug. The FDA’s new aggressive response to off-label uses of quinine are intended to protect the health and safety of the public and set an example to other companies that attempt to market potentially-dangerous substances as safe. These actions will hopefully save untold lives in the years to come.
To learn more about Quinine side effects or the Dangers of Quinine, please visit our website at http://www.resource4thepeople.com/defectivedrugs/quinine.html This article may be freely reprinted as long as this resource box is included and all links stay intact as hyperlinks.
This Article has been viewed 1,512 times. (Not updated in real-time.)
No comments yet.We want your comments! If you can read this, you don't have javascript enabled, so you can't use this comment system. Please enable javascript.